查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1262029

PCOS 診斷市場全球行業規模、份額、趨勢、機會、預測，2018-2028 年，按測試類型、最終用戶、地區、競爭

PCOS Diagnostic Market Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Test Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球 PCOS 診斷市場將在預測期內穩步增長。 多囊卵巢綜合徵病例的增加將支持全球多囊卵巢綜合徵診斷市場，因為它將增加對有效診斷程序和試劑的需求，為市場帶來積極效益。 PCOS 發病率的上升、對早期診斷的需求增加、久坐不動的生活方式的延長以及育齡婦女的肥胖推動了全球多囊卵巢綜合徵 (PCOS) 診斷市場的顯著增長。

PCOS 在育齡婦女中的患病率上升

據稱，在全球範圍內，PCOS 影響了超過 6%-10% 的育齡婦女。 根據全球疾病負擔研究，2017 年，15-49 歲女性的患病率和嚴重程度佔 PCOS 發病率的 155 萬（95% 不確定區間）。 2007年和2017年，厄瓜多爾、秘魯、玻利維亞、日本和百慕大的年齡標化發病率和發病率最高。

在阿聯酋女性中也發現了 PCOS 的患病率最高，使其成為該國不孕的主要原因。 同樣，德克薩斯女子大學通過診斷方法對 PCOS 患病率進行的一項研究發現，在正式診斷為 PCOS 的人群中患病率為 28.5%，而在未經正式診斷的女性中患病率為 40.5%。這已被證實顯示出更高的患病率。

久坐不動的生活方式和人口肥胖率上升

全球女性肥胖的發生率幾乎翻了一番，從 6% 增加到 10%。 一項研究發現，肥胖和非肥胖女性的 PCOS 發病率奇比為 2.77。 同樣，在西班牙女性中進行的 ClinicalTrials.Gov 結果顯示，體重健康的女性患 PCOS 的患病率為 5.5%，而肥胖女性的患病率高出 28.3%。已確認。 由於多囊卵巢綜合徵最常見的原因是久坐不動的生活方式，多見於居住在城市地區的年輕人，可能是由於適應不良的飲食習慣、缺乏運動和過度壓力等不活躍的生活方式所致。 在此背景下，預計 PCOS 診斷市場將在全球範圍內出現高需求。

PCOS早期診斷需求增加

據說PCOS極有可能患上胰島素抵抗、2型糖尿病、高膽固醇、高血壓、心髒病、流產/早產、抑鬱、焦慮和子宮出血等各種疾病。重要疾病。

根據發表在《環境研究與公共衛生》雜誌上的一項研究，在尋求醫療救助的人群中，PCOS 仍未確診的比例非常高，高達 75%。估計。 與過量雄激素和月經異常相關的症狀對女性的生活質量具有顯著的負面影響。 因此，為防止問題惡化，患者應與醫生討論他們的症狀，並可能進行進一步檢查以避免並發症。 青少年 PCOS 是一個日益嚴重的健康問題。 因此，早期干預和鼓勵健康的生活方式對於預防進一步的發病率是必要的。 根據診斷，醫生建議患者使用激素避孕藥來降低子宮內膜炎的風險、調節月經、治療皮膚痤瘡和減少多餘的體毛。

近期發展

PCOS 宣傳月（9 月 1 日至 30 日）

PCOS 宣傳月是聯邦政府指定的活動，於 9 月舉行，旨在傳播對患有 PCOS 的女性的認識和支持。 全國多囊卵巢綜合症協會贊助了 PCOS 挑戰賽，這是最大的非營利宣傳和宣傳組織，旨在為多囊卵巢綜合症患者提供支持。 它為全球超過 55,000 名會員提供服務。 該非營利組織每年通過多個電視和廣播節目、在線和離線支持小組、教育、贈款、意識和宣傳工作來幫助受 PCOS 影響的人。 提高公眾、女孩和婦女對 PCOS 的認識和教育，告知診斷和治療方案，並推動早期診斷的需求。

可定制

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢

第 4 章 VOC（客戶之聲）

第5章臨床試驗分析

  • 正在進行的臨床試驗
  • 已完成臨床試驗
  • 已完成臨床試驗
  • 管道細分（按開發階段）
  • 管道細分（按狀態
  • 管道分解（按測試應用）
  • 按地區劃分的渠道細分
  • 臨床試驗熱圖

第 6 章 PCOS 診斷的全球市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按測試類型（驗血、骨盆檢查、經陰道超聲）
    • 最終用戶（醫院/診所、生育診所、其他）
    • 按地區
    • 按公司分類（2022 年）
  • 產品市場地圖
    • 按測試類型
    • 最終用戶
    • 按地區

第7章北美PCOS診斷市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按測試類型
    • 最終用戶
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章歐洲 PCOS 診斷市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按測試類型
    • 最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 9 章亞太 PCOS 診斷市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按測試類型
    • 最終用戶
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳大利亞

第 10 章南美 PCOS 診斷市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按測試類型
    • 最終用戶
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 11 章中東和非洲 PCOS 診斷市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按測試類型
    • 最終用戶
    • 按國家
  • MEA：國家分析
    • 南非 PCOS 診斷
    • 沙特阿拉伯 PCOS 診斷
    • 阿聯酋 PCOS 診斷
    • 科威特 PCOS 診斷

第 12 章市場動態

  • 司機
  • 做

第13章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第14章競爭格局

  • 業務概覽
  • 企業概況
  • 產品和服務
  • 財務（適用於上市公司）
  • 近期發展狀況
  • SWOT 分析
    • Siemens Healthineers AG
    • GE Healthcare
    • Mindray Medical International Limited
    • Esaote S.p.A
    • Telemed Medical Systems
    • Shantou Institute of Ultrasonic Instruments Co., Ltd.（SIUI）
    • BK Medical
    • Alpinion Medical Systems
    • Mindray ZONARE Medical Systems
    • Xianfeng Ultrasound Medical

第 15 章戰略建議

簡介目錄
Product Code: 14692

Global PCOS Diagnostic Market is expected to grow at a steady rate over the forecast period. The growing prevalence of polycystic ovarian syndrome will support the global Polycystic Ovarian Syndrome Diagnostic market, as the increased cases of PCOS will elevate the demand for effective diagnostic procedures and medications, thus benefitting the market positively. The growing PCOS occurrence, increased demand for early diagnosis, extended sedentary lifestyle, and obesity among women of reproductive age will help the polycystic ovarian syndrome (PCOS) diagnostic market to grow significantly around the globe.

Polycystic Ovarian Syndrome (PCOS) is a condition arising due to hormonal imbalance affecting women of childbearing age. It is a symptomatic disorder characterized by irregular or no periods and increased levels of male hormones in the body. According to the Centers for Disease Control and Prevention, approximately 5 million women of reproductive age in the United States have a polycystic ovarian syndrome. The rise in cases will hence directly offer opportunities for the PCOS diagnostic market to grow significantly over the forecast period.

Rising Prevalence of PCOS Among Females of Reproductive Age

Globally, PCOS affects over 6% -10% of women of reproductive age. According to the Global Burden of Disease study, in 2017, prevalence, as well as the severity of problems among women of age 15-49 years, accounted for 1.55 million (95% uncertainty intervals) incident cases of PCOS. In the years 2007 and 2017, the highest age-standardized incidences and disease occurrence rates were observed in Ecuador, Peru, Bolivia, Japan, and Bermuda.

Also, the highest prevalence of PCOS is found to be among women in UAE and is a leading cause of infertility in the country. Similarly, according to a research study performed by Texas Woman's University to record the prevalence of PCOS based on the diagnosis method, it was observed that 28.5% of the PCOS prevalence was indicated for formally diagnosed PCOS respondents, and a larger account of prevalence, i.e., around 40.5% was indicated among those women without a formal diagnosis.

Sedentary Lifestyle and Increasing Cases of Obesity Among the Population

The increasing rate of occurrence of obesity among women has almost doubled, i.e., from 6% -10% around the globe. A study revealed that there is an odd ratio of 2.77 for the development of PCOS among obese women and their non-obese women counterparts. Similarly, According to ClinicalTrials.Gov results based on a study conducted among women in Spain, it was observed that there were ~28.3% more chances of PCOS in obese women, compared to a 5.5% prevalence of PCOS among healthy-weighted women. A sedentary lifestyle is the most common cause of PCOS and is therefore observed most in the younger generation among the urban population due to increased bad eating habits and inactive lifestyle adaptation such as no physical exercise and excessive stress. This aspect is propelling the PCOS diagnostic market for higher demand across the globe.

Increase in Demand for Early Diagnosis Of PCOS

Since PCOS has been associated with a higher chance of acquiring several illnesses, such as insulin resistance, type 2 diabetes, high cholesterol, high blood pressure, heart disease, miscarriage or premature birth, depression, anxiety, bleeding from the uterus, etc., therefore, early detection of the condition is highly crucial.

According to a research study published in Environmental Research and Public health journal, PCOS has a very high percentage of individuals who remained undiagnosed when visiting their doctor, which is a number estimated to be as high as 75%. The symptoms linked to excess androgen and abnormalities in periods have a significant negative impact on women's quality of life. Therefore, in order to prevent the problem from getting worse, the patient should consult a doctor about their symptoms and possibly pursue further testing to avoid complications. Adolescent PCOS is a growing health concern. Thus, early interventions and the encouragement of healthy lifestyles are required to prevent additional morbidities. In accordance with the diagnosis, the doctor may advise the patient to use hormonal birth control pills to reduce the risk of endometrial instances, regulate the period, treat skin acne, and reduce excess body hair.

Recent Developments

PCOS Awareness Month (1September - 30 September)

PCOS awareness month is a federally designated event, which is organized in September month and inaugurated as an initiative for spreading awareness and support among women suffering from PCOS. The National Polycystic Ovary Syndrome Association is sponsoring the largest non-profit support and advocacy organization PCOS Challenge, established to provide support to people with the polycystic ovarian syndrome. It serves over 55,000 members across the globe. This non-profit organization supports PCOS-affected individuals each year through several television and radio programming, online and offline support groups, education, grants, awareness, and advocacy initiatives. By increasing awareness & education about PCOS among the general public, girls, and women, they provide information on diagnosis and treatment options, thereby promoting the need for early diagnosis.

Market Segmentation

The global PCOS Diagnosis market can be segmented on the test type, end user, and region. Based on the test type, the market can be segmented into Blood tests, pelvic exams, and Transvaginal ultrasounds. Depending on the end user, the market can be segmented into Hospitals & Clinics, Fertility Clinics, and Others.

Market Players

Siemens Healthineers AG, GE Healthcare, Mindray Medical International Limited, Esaote S.p.A, Telemed Medical Systems, Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI), BK Medical, Alpinion Medical Systems, Mindray ZONARE Medical Systems, Xianfeng Ultrasound Medical are some of the leading companies operating in the market.

Report Scope

In this report, Global PCOS Diagnostic Market, the market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

PCOS Diagnostic Market, By Test Type:

  • Blood tests
  • Pelvic exam
  • Ultrasound (Transvaginal)

PCOS Diagnostic Market, By End User:

  • Hospitals & Clinics
  • Fertility clinics
  • Others

PCOS Diagnostic Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global PCOS Diagnostic Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global PCOS Diagnosis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type (Blood test, Pelvic exam, Transvaginal Ultrasound)
    • 6.2.2. By End Users (Hospitals & Clinics, Fertility Clinics, Others)
    • 6.2.3. By Region
    • 6.2.4. By Company (2022)
  • 6.3. Product Market Map
    • 6.3.1. By Test Type
    • 6.3.2. By End Users
    • 6.3.3. By Region

7. North America PCOS Diagnosis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By End Users
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States PCOS Diagnosis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By End Users
    • 7.3.2. Mexico PCOS Diagnosis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By End Users
    • 7.3.3. Canada PCOS Diagnosis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By End Users

8. Europe PCOS Diagnosis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By End Users
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France PCOS Diagnosis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By End Users
    • 8.3.2. Germany PCOS Diagnosis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By End Users
    • 8.3.3. United Kingdom PCOS Diagnosis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By End Users
    • 8.3.4. Italy PCOS Diagnosis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By End Users
    • 8.3.5. Spain PCOS Diagnosis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By End Users

9. Asia-Pacific PCOS Diagnosis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By End Users
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China PCOS Diagnosis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By End Users
    • 9.3.2. India PCOS Diagnosis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By End Users
    • 9.3.3. South Korea PCOS Diagnosis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By End Users
    • 9.3.4. Japan PCOS Diagnosis Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Test Type
        • 9.3.4.2.2. By End Users
    • 9.3.5. Australia PCOS Diagnosis Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Test Type
        • 9.3.5.2.2. By End Users

10. South America PCOS Diagnosis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By End Users
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil PCOS Diagnosis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By End Users
    • 10.3.2. Argentina PCOS Diagnosis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By End Users
    • 10.3.3. Colombia PCOS Diagnosis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By End Users

11. Middle East and Africa PCOS Diagnosis Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Test Type
    • 11.2.2. By End Users
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa PCOS Diagnosis Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Test Type
        • 11.3.1.2.2. By End Users
    • 11.3.2. Saudi Arabia PCOS Diagnosis Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Test Type
        • 11.3.2.2.2. By End Users
    • 11.3.3. UAE PCOS Diagnosis Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Test Type
        • 11.3.3.2.2. By End Users
    • 11.3.4. Kuwait PCOS Diagnosis Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Test Type
        • 11.3.4.2.2. By End Users

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (In Case of Listed Companies)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. Siemens Healthineers AG
    • 14.6.2. GE Healthcare
    • 14.6.3. Mindray Medical International Limited
    • 14.6.4. Esaote S.p.A
    • 14.6.5. Telemed Medical Systems
    • 14.6.6. Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
    • 14.6.7. BK Medical
    • 14.6.8. Alpinion Medical Systems
    • 14.6.9. Mindray ZONARE Medical Systems
    • 14.6.10. Xianfeng Ultrasound Medical

15. Strategic Recommendations